Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
- Status
- COMPLETED
- Phase
- N/A
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis
- Status
- COMPLETED
- Phase
- PHASE1
GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
- Status
- WITHDRAWN
- Phase
- PHASE2
Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1